Search results
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
San Francisco Chronicle· 2 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly’s Q1
Forbes· 6 days agoEli Lilly stock (NYSE: LLY) will report its Q1 results on Tuesday, April 30. The pharmaceutical...
Weight loss drugs are so hot that Eli Lilly is expecting $2 billion more in sales this year
Quartz· 2 days agoEli Lilly stock jumped 5% during Tuesday morning trading to about $773 a share after the pharma giant reported better-than-expected sales of its weight ...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
NBC Bay Area· 2 days agoEli Lilly reported first-quarter adjusted profit that topped Wall Street's expectations. The company also hiked its full-year guidance on strong sales of ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion By Reuters
Investing.com· 2 days agoLilly said it expects significant production increases in the second half of the year for its...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters via Yahoo News· 2 days ago(Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug...
...Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and...
Benzinga· 1 day agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Lilly reports earnings, raises forecast | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 23 hours agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report
Benzinga via Yahoo Finance· 3 days agoEli Lilly and Company (NYSE:LLY) is set to report first-quarter earnings on Tuesday, April 30....
Eli Lilly lifts 2024 sales view by $2 billion on weight-loss drug demand By Reuters
Investing.com· 2 days agoMost doses of Mounjaro and Zepbound are expected to be available in limited amounts through the...